TIMP3 and triple-A syndrome: MiR-181b in AAA negatively modulates the expression of macrophage tissue inhibitor of metalloproteinase-3 (TIMP3) (Di Gregoli et al., 2017), and hsa-circ-0005360 is predicated to bind to miR-181b and may regulate the progression of AAA (Zhou et al., 2020).